Close Menu

NEW YORK – Shares of Twist Bioscience rose 12 percent in afternoon trading on the Nasdaq on speculation that the synthetic DNA manufacturer is close to settling a trade secrets lawsuit filed by Agilent Technologies.

The San Francisco-based company's stock opened Thursday trading at $26.83 and the shares rose sharply in mid-afternoon trade to $30.11.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.